封面
市场调查报告书
商品编码
1452781

全球下腔静脉过滤器市场规模、份额、成长分析(按产品类型和地点)- 2024-2031 年产业预测

Global Inferior Vena Cava Filters Market Size, Share, Growth Analysis, By Product Type(Retrievable Filters and Permanent Filters), By Placement(Permanent Placement, Temporary Placement) - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球下腔静脉过滤器市场规模将为7.836亿美元,从2023年的8.4966亿美元增长到2031年的16.2345亿美元,预测期(2024-2031年预计复合年增长率为8.43%) 。

下腔静脉 (IVC) 过滤器市场透过在血栓到达肺部之前阻止血栓,在避免与血栓相关的危及生命的情况方面发挥关键作用。这些医疗设备被插入下腔静脉(将脱氧血液从下半身输送到心臟的主要静脉),以捕获血栓并降低肺动脉栓塞的风险。静脉血栓栓塞症(VTE)和深层静脉栓塞症(DVT)的盛行率上升以及人们对这些疾病的认识的提高推动了市场扩张。人口老化、久坐的生活方式和手术干预等多种因素都会导致血栓风险增加,从而推动对下腔静脉过滤器的需求。技术进步,包括可回收和可调节的过滤器设计,提高了其有效性和安全性,从而推动了市场成长。此外,市场还受益于微创手术的普及以及医学影像技术的进步,使准确的过滤器放置变得更加容易。北美地区由于强大的医疗基础设施和较高的 VTE 盛行率而在市场上占据主导地位,而亚太地区则由于医疗成本和意识的上升而经历了快速增长。此外,人口老化的欧洲也占有很大的市场占有率。随着IVC过滤技术的不断发展以及其在高风险患者中的应用不断增加,它将不断改进以满足预防血栓相关併发症和改善患者治疗效果的关键需求,市场处于有利地位。

目录

执行摘要

  • 市场概况
  • 命运之轮

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管环境
  • 波特的分析
  • 对未来中断的特殊考虑

按产品类型分類的全球下腔静脉过滤器市场

  • 市场概况
  • 可回收过滤器/永久过滤器

全球下腔静脉过滤器市场按地区划分

  • 市场概况
  • 永久安置
  • 临时安置

全球下腔静脉过滤器市场规模(按地区)

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • Boston Scientific Corporation
  • Cook Medical
  • Cordis Corporation(a Cardinal Health company)
  • B. Braun Melsungen AG
  • CR Bard, Inc.(acquired by BD)
  • Johnson & Johnson
  • Medtronic plc
  • Abbott Laboratories
  • Terumo Corporation
  • Becton, Dickinson and Company(BD)
  • Merit Medical Systems, Inc.
  • Argon Medical Devices, Inc.
  • Teleflex Incorporated
  • Cardinal Health, Inc.
  • ALN Implants Chirurgicaux
简介目录
Product Code: SQMIG35A2557

Global Inferior Vena Cava Filters Market size was valued at USD 783.6 million in 2022 and is poised to grow from USD 849.66 million in 2023 to USD 1623.45 million by 2031, growing at a CAGR of 8.43% in the forecast period (2024-2031).

The market for inferior vena cava (IVC) filters plays a crucial role in averting life-threatening situations associated with blood clots by intercepting them before they reach the lungs. These medical devices are inserted into the inferior vena cava, the primary vein transporting deoxygenated blood from the lower body to the heart, with the purpose of trapping blood clots and reducing the risk of pulmonary embolism. The market's expansion is fueled by the escalating prevalence of venous thromboembolism (VTE) and deep vein thrombosis (DVT) cases, alongside heightened awareness of these conditions. Various factors such as an aging demographic, sedentary lifestyles, and surgical interventions contribute to the heightened clotting risk, thereby boosting demand for IVC filters. Technological advancements, including retrievable and adjustable filter designs, augment their effectiveness and safety, thereby driving market growth. Moreover, the market benefits from the increasing adoption of minimally invasive procedures and advancements in medical imaging techniques, facilitating precise filter placement. North America dominates the market, thanks to its robust healthcare infrastructure and high incidence of VTE cases, while the Asia-Pacific region experiences rapid growth due to rising healthcare expenditure and awareness. Europe also holds a significant market share due to its aging population. With ongoing innovation in IVC filter technologies and their increasing adoption among high-risk patients, the market is well-positioned to address the critical necessity of preventing blood clot-related complications and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inferior Vena Cava Filters Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inferior Vena Cava Filters Market Segmental Analysis

The global inferior vena cava filters market is segmented by Product Type, Placement, End User, and Region. Based on Product Type the market is segmented as, Retrievable Filters, and Permanent Filters. Based on Placement the market is Permanent Placement, Temporary Placement. Based on End-User the market is segmented as, Hospitals, Ambulatory Surgical Centers. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA).

Drivers of the Global Inferior Vena Cava Filters Market

The escalating incidence of venous thromboembolism (VTE) incidents, encompassing both deep vein thrombosis (DVT) and pulmonary embolism (PE), underscores the necessity for inferior vena cava filters as proactive interventions. With sedentary lifestyles, prolonged immobility, and certain medical conditions predisposing individuals to VTE, the implementation of these filters serves as a crucial preventive measure against potentially life-threatening complications. As the healthcare landscape continues to evolve, the development of advanced filter technologies and their accessibility in diverse healthcare settings becomes imperative in addressing this growing healthcare concern.

Restraints in the Global Inferior Vena Cava Filters Market

The insertion of an inferior vena cava (IVC) filter may result in complications such as migration, fracture, and perforation, prompting apprehensions regarding the enduring safety and effectiveness of such devices. These concerns underscore the importance of vigilant monitoring and thorough assessment of patients who have undergone IVC filter placement. Moreover, ongoing research endeavors are essential to continually refine these interventions and enhance patient outcomes, emphasizing the imperative for collaborative efforts between medical practitioners and researchers in this field.

Market Trends of the Global Inferior Vena Cava Filters Market

There's a notable trend in the market favoring retrievable filters, propelled by their adaptable nature and the promise of easy removal, which resonates with the ethos of patient-centered healthcare and the imperative to mitigate long-term hazards. This shift underscores a growing recognition within the medical community of the importance of interventions that can be tailored to individual patient needs while also prioritizing safety and long-term well-being. Additionally, retrievable filters offer a dynamic solution for addressing evolving patient conditions, serving as a proactive measure in minimizing potential complications associated with prolonged implantation.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Inferior Vena Cava Filters Market by Product Type

  • Market Overview
  • Retrievable Filters and Permanent Filters

Global Inferior Vena Cava Filters Market by Placement

  • Market Overview
  • Permanent Placement
  • Temporary Placement

Global Inferior Vena Cava Filters Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cordis Corporation (a Cardinal Health company)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.R. Bard, Inc. (acquired by BD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Argon Medical Devices, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALN Implants Chirurgicaux
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments